Business
Isodiol International Inc. Announces Licensing Agreement With Livecare Health Canada Inc. and Appoints Dr. Amit Mathur to Medical Advisory Board
Isodiol International Inc. Announces Licensing Agreement With Livecare Health Canada Inc. and Appoints Dr. Amit Mathur to Medical Advisory Board.
About this update from Isodiol International Inc
[{"type":"text","content":"\n\n VANCOUVER, British Columbia, Jan. 26, 2018 (GLOBE NEWSWIRE) -- Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has signed a licensing agreement with Livecare Health Canada Inc. (Livecare), an organization founded and operated by Doctors dedicated to giving patients access to quality, real-time healthcare, regardless of where they are located.\n Livecare is a Vancouver-based company committed to empowering health care through technology.  Founded by Dr. Mark Godley in 2012, they offer digital technologies that connect Doctors & Allied Health Care Providers to their Patients via secure, encrypted, face-to-face video and messaging. Under the terms of the licensing agreement, Isodiol will license the Telehealth Platform (Platform) and operate it under a white label in connection with the marketing of all its products.  The license shall grant Isodiol the exclusive right to use the Platform relating to all cannabis, cannabis-derived, cannabinoid and phytoceutical products and related services.   Livecare will customize and convey the Platform for Isodiol and will assist in marketing and commercializing the Platform on a global scale. The Platform is generally described as an interconnectivity network with a cloud-based user interface that provides access by multiple categories of users, including patients, physicians, other medical professionals, pharmaceutical providers, and on personal computing devices to deliver health and wellness solutions without regard to the physical location of the users. “Isodiol is extremely proud of this innovative step, where our consumers will now have the ability to consult with medical experts via the Telehealth Platform technology,” said CEO of Isodiol, Marcos Agramont.  “Our customers are extremely valued and consumers around the globe, particularly in urban areas, will now face little to no inconveniences when seeking health and wellness improvement.” As a part of the licensing agreement, the Company will pay Livecare a royalty dependant on the jurisdiction of commercialization.  The company will also is...